US Stock Market Move | Moderna (MRNA.US) rises 5%, with its stock price approaching an all-time high.

On Monday, Moderna (MRNA.US) rose more than 8% in early trading, and as of press time, its gain narrowed to 5%, at $229.69, with the stock price approaching its all-time high. On the news front, on October 17, Moderna and Merck & Co., Inc. presented the Phase III melanoma study results for their personalized cancer therapy intismeran autogene in combination with Keytruda, and reports noted that the candidate therapy achieved positive progress.